• Mashup Score: 3

    Jackie Rodriguez was told she’d need to have her leg amputated after she was diagnosed with a rare bone cancer called osteochondroma-associated de-differentiated chondrosarcoma. Instead, she came to MD Anderson, where a limb salvage surgery saved her leg and her life.

    Tweet Tweets with this article
    • At 21, Jackie Rodriguez wasn't thinking about having kids. But then she faced a rare bone cancer, so she pursued fertility preservation with our Dr. Terri Woodard. “I’m glad now that I did it,” Jackie says: https://t.co/NAjGN9idks @DrTLWoodard @IBC_Bank #AYACancer #EndCancer

  • Mashup Score: 0

    Survivors of adolescent and young-adult acute myeloid leukemia and acute lymphoblastic leukemia had lower long-term survival rates than the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention. Researchers also observed disparities in long-term survival among this population based on age, sex and ethnicity.

    Tweet Tweets with this article
    • Study published in @CEBP_AACR shows that younger #leukemia survivors have worse long-term survival outcomes than the general population Read more here: https://t.co/h5gy4qieHi #AYACancer #oncology @mroth_MD @MDAndersonNews @bcmhouston @TuftsMedicalCtr @DukeMedSchool

  • Mashup Score: 3

    Survivors of adolescent and young-adult acute myeloid leukemia and acute lymphoblastic leukemia had lower long-term survival rates than the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention. Researchers also observed disparities in long-term survival among this population based on age, sex and ethnicity.

    Tweet Tweets with this article
    • "More attention is needed on providing patients access to long-term, high-quality [cancer] survivorship care,” says Michael E. Roth, MD of @MDAndersonNews Read more: https://t.co/eQ5uwe0tnI #onctwitter #AYACancer @mroth_MD https://t.co/lg7yNygoSB

  • Mashup Score: 2

    Survivors of adolescent and young-adult acute myeloid leukemia and acute lymphoblastic leukemia had lower long-term survival rates than the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention. Researchers also observed disparities in long-term survival among this population based on age, sex and ethnicity.

    Tweet Tweets with this article
    • "More attention is needed on providing patients access to long-term, high-quality [cancer] survivorship care,” says Michael E. Roth, MD of @MDAndersonNews Read more: https://t.co/h5gy4qieHi #onctwitter #AYACancer @mroth_MD https://t.co/wgaxkyRQ4Y

  • Mashup Score: 7

    Survivors of adolescent and young-adult acute myeloid leukemia and acute lymphoblastic leukemia had lower long-term survival rates than the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention. Researchers also observed disparities in long-term survival among this population based on age, sex and ethnicity.

    Tweet Tweets with this article
    • Study published in @CEBP_AACR shows that younger #leukemia survivors have worse long-term survival outcomes than the general population Read more here: https://t.co/h5gy4qieHi #AYACancer #oncology @mroth_MD @MDAndersonNews @bcmhouston @TuftsMedicalCtr @DukeMedSchool

    • Study published in @CEBP_AACR shows that younger #leukemia survivors have worse long-term survival outcomes than the general population Read more here: https://t.co/eQ5uwdISwa #AYACancer #oncology @mroth_MD @MDAndersonNews @bcmhouston @TuftsMedicalCtr @DukeMedSchool

  • Mashup Score: 5

    Cancer whole-genome and transcriptome sequencing (cWGTS) has been challenging to implement in clinical settings. Here, the authors develop a workflow to deliver robust cWGTS analyses and reports within clinically-relevant timeframes for paediatric, adolescent and young adult solid tumour patients.

    Tweet Tweets with this article
    • Impressive turnaround times for cancer whole genome & transcriptome sequencing (cWGTS) - 9 days from start to finish - and application to pediatric & #AYAcancer From @PapaemmanuilLab and colleagues https://t.co/r1zAyQTkmH https://t.co/dvP5D0Nw4N